Abstract
Background
Subclinical atrial fibrillation (SCAF) may represent a cause of embolic stroke of undetermined source (ESUS) and its detection has important implications for secondary prevention with anticoagulation. Indications to implantable cardiac monitors (ICM) include SCAF detection. The aims of this study were to (1) evaluate the frequency of ICM-detected SCAF; (2) determine predictors of SCAF; and (3) identify patients who would benefit most from ICM implantation.
Methods
Between February 2017 and November 2020, all consecutive patients referred for ICM implantation after a diagnosis of ESUS and without previous history of atrial fibrillation or atrial flutter were included in this study. SCAF was diagnosed if the ICM electrogram demonstrated an episode of irregularly irregular rhythm without distinct P waves lasting > 2 min.
Results
We enrolled 109 patients (age 66, SD = 13 years; 36% females). During a median follow-up of 19.2 (IQR 11.0–27.5) months, SCAF episodes were detected in 36 (33%) patients. Only abnormal P wave terminal force in lead V1, left atrial end-systolic indexed volume > 34 ml/m2, and BMI > 25 kg/m2 were independently associated with an increased risk of SCAF (HR 2.44, 95% CI 1.14–5.21, p = 0.021; HR 2.39, 95% CI 1.11–5.13, p = 0.026; and HR 2.64, 95% CI 1.06–6.49, p = 0.036 respectively). The ROC curve showed that the presence of all three parameters had the best accuracy (74%) to predict SCAF detection (sensitivity 39%, specificity 91%).
Conclusion
A multiparametric evaluation has the best accuracy to predict SCAF in ESUS patients and may help identifying those who would benefit most from ICM.
Similar content being viewed by others
References
Marini C, De Santis F, Sacco S et al (2005) Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study. Stroke 36(6):1115–1119. https://doi.org/10.1161/01.STR.0000166053.83476.4a
Sposato LA, Cipriano LE, Saposnik G, Ruíz Vargas E, Riccio PM, Hachinski V (2015) Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol 14(4):377–387. https://doi.org/10.1016/S1474-4422(15)70027-X
Krishnamurthi RV, Barker-Collo S, Parag V et al (2018) Stroke incidence by major pathological type and ischemic subtypes in the Auckland regional community stroke studies: changes between 2002 and 2011. Stroke 49(1):3–10. https://doi.org/10.1161/STROKEAHA.117.019358
Li L, Yiin GS, Geraghty OC et al (2015) Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study. Lancet Neurol 14(9):903–913. https://doi.org/10.1016/S1474-4422(15)00132-5
Hart RG, Diener HC, Coutts SB et al (2014) Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol 13(4):429–438. https://doi.org/10.1016/S1474-4422(13)70310-7
Hannon N, Sheehan O, Kelly L et al (2010) Stroke associated with atrial fibrillation–incidence and early outcomes in the north Dublin population stroke study. Cerebrovasc Dis 29(1):43–49. https://doi.org/10.1159/000255973
Ziegler PD, Koehler JL, Mehra R (2006) Comparison of continuous versus intermittent monitoring of atrial arrhythmias. Heart Rhythm 3(12):1445–1452. https://doi.org/10.1016/j.hrthm.2006.07.030
Charitos EI, Stierle U, Ziegler PD et al (2012) A comprehensive evaluation of rhythm monitoring strategies for the detection of atrial fibrillation recurrence: insights from 647 continuously monitored patients and implications for monitoring after therapeutic interventions [published correction appears in Circulation. Circulation 126(7):806–814. https://doi.org/10.1161/CIRCULATIONAHA.112.098079
Sanna T, Diener HC, Passman RS et al (2014) Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 370(26):2478–2486. https://doi.org/10.1056/NEJMoa1313600
Tsivgoulis G, Katsanos AH, Köhrmann M et al (2019) Duration of implantable cardiac monitoring and detection of atrial fibrillation in ischemic stroke patients: a systematic review and meta-analysis. J Stroke 21(3):302–311. https://doi.org/10.5853/jos.2019.01067
Hindricks G, Potpara T, Dagres N et al (2021) 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 42(5):373–498. https://doi.org/10.1093/eurheartj/ehaa612
Li YG, Bisson A, Bodin A et al (2019) C2 HEST score and prediction of incident atrial fibrillation in poststroke patients: a French nationwide study. J Am Heart Assoc 8(13):e012546. https://doi.org/10.1161/JAHA.119.012546
Acampa M, Lazzerini PE, Guideri F et al (2019) Electrocardiographic predictors of silent atrial fibrillation in cryptogenic stroke. Heart Lung Circ 28(11):1664–1669. https://doi.org/10.1016/j.hlc.2018.10.020
Acampa M, Lazzerini PE, Martini G (2018) Atrial cardiopathy and sympatho-vagal imbalance in cryptogenic stroke: pathogenic mechanisms and effects on electrocardiographic markers. Front Neurol 9:469. https://doi.org/10.3389/fneur.2018.00469
Bayés de Luna A, Escobar-Robledo LA, Aristizabal D et al (2018) Atypical advanced interatrial blocks: definition and electrocardiographic recognition. J Electrocardiol. 51(6):1091–1093. https://doi.org/10.1016/j.jelectrocard.2018.09.004
Ziegler PD, Rogers JD, Ferreira SW et al (2017) Long-term detection of atrial fibrillation with insertable cardiac monitors in a real-world cryptogenic stroke population. Int J Cardiol 244:175–179. https://doi.org/10.1016/j.ijcard.2017.06.039
Triantafyllou S, Katsanos AH, Dilaveris P et al (2020) Implantable cardiac monitoring in the secondary prevention of cryptogenic stroke. Ann Neurol 88(5):946–955. https://doi.org/10.1002/ana.25886
Cuadrado-Godia E, Benito B, Ois A et al (2020) Ultra-early continuous cardiac monitoring improves atrial fibrillation detection and prognosis of patients with cryptogenic stroke. Eur J Neurol 27(2):244–250. https://doi.org/10.1111/ene.14061
Öner A, Lips T, Walter U et al (2020) Detection of arrhythmia using an implantable cardiac monitor following a cryptogenic stroke: a single-center observational study. Eur J Med Res. 25(1):25. https://doi.org/10.1186/s40001-020-00424-3
Ungar A, Pescini F, Rafanelli M et al (2021) Detection of subclinical atrial fibrillation after cryptogenic stroke using implantable cardiac monitors. Eur J Intern Med 92:86–93. https://doi.org/10.1016/j.ejim.2021.06.022
Ricci B, Chang AD, Hemendinger M et al (2018) A simple score that predicts paroxysmal atrial fibrillation on outpatient cardiac monitoring after embolic stroke of unknown source. J Stroke Cerebrovasc Dis 27(6):1692–1696. https://doi.org/10.1016/j.jstrokecerebrovasdis.2018.01.028
Melis F, Guido M, Amellone C et al (2021) Prevalence and predictors of atrial fibrillation in patients with embolic stroke of undetermined source: a real-life single-center retrospective study. Neurol Sci 42(9):3707–3714. https://doi.org/10.1007/s10072-020-04963-9
Sethi A, Buescher M, Garberich R, Hoffman E, Langeberg T, Abdelhadi R, Katsiyiannis W, Moore J, Tang C, Sengupta J (2017) Evolution of implantable cardiac monitors: a comparison of Reveal XT and LINQ patient selection, arrhythmia detection, and clinical outcomes. J Minneapolis Heart Inst Found: Fall/Winter 1(2):130–135
Edwards SJ, Wakefield V, Jhita T, Kew K, Cain P, Marceniuk G (2020) Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke: a systematic review and economic evaluation. Health Technol Assess 24(5):1–184. https://doi.org/10.3310/hta24050
Haeusler KG, Gröschel K, Köhrmann M et al (2018) Expert opinion paper on atrial fibrillation detection after ischemic stroke. Clin Res Cardiol 107(10):871–880. https://doi.org/10.1007/s00392-018-1256-9
Thijs VN, Brachmann J, Morillo CA et al (2016) Predictors for atrial fibrillation detection after cryptogenic stroke: Results from CRYSTAL AF. Neurology 86(3):261–269. https://doi.org/10.1212/WNL.0000000000002282
Poli S, Diedler J, Härtig F et al (2016) Insertable cardiac monitors after cryptogenic stroke–a risk factor based approach to enhance the detection rate for paroxysmal atrial fibrillation. Eur J Neurol 23(2):375–381. https://doi.org/10.1111/ene.12843
Kamel H, Okin PM, Elkind MS, Iadecola C (2016) Atrial fibrillation and mechanisms of stroke: time for a new model. Stroke 47(3):895–900. https://doi.org/10.1161/STROKEAHA.115.012004
Kreimer F, Aweimer A, Pflaumbaum A, Mügge A, Gotzmann M (2021) Impact of P-wave indices in prediction of atrial fibrillation-Insight from loop recorder analysis. Ann Noninvasive Electrocardiol 26(5):e12854. https://doi.org/10.1111/anec.12854
Mendieta G, Guasch E, Weir D et al (2020) Advanced interatrial block: a predictor of covert atrial fibrillation in embolic stroke of undetermined source. J Electrocardiol 58:113–118. https://doi.org/10.1016/j.jelectrocard.2019.11.050
Marks D, Ho R, Then R et al (2021) Real-world experience with implantable loop recorder monitoring to detect subclinical atrial fibrillation in patients with cryptogenic stroke: The value of p wave dispersion in predicting arrhythmia occurrence. Int J Cardiol 327:86–92. https://doi.org/10.1016/j.ijcard.2020.11.019
Li TYW, Yeo LLL, Ho JSY et al (2021) Association of electrocardiographic P-wave markers and atrial fibrillation in embolic stroke of undetermined source. Cerebrovasc Dis 50(1):46–53. https://doi.org/10.1159/000512179
Huang Z, Zheng Z, Wu B et al (2020) Predictive value of P wave terminal force in lead V1 for atrial fibrillation: a meta-analysis. Ann Noninvasive Electrocardiol 25(4):e12739. https://doi.org/10.1111/anec.12739
Okin PM, Kamel H, Kjeldsen SE, Devereux RB (2016) Electrocardiographic left atrial abnormalities and risk of incident stroke in hypertensive patients with electrocardiographic left ventricular hypertrophy. J Hypertens 34(9):1831–1837. https://doi.org/10.1097/HJH.0000000000000989
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
The study protocol was approved by the local ethic committees of the two institution.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Del Monte, A., Rivezzi, F., Giacomin, E. et al. Multiparametric identification of subclinical atrial fibrillation after an embolic stroke of undetermined source. Neurol Sci 44, 979–988 (2023). https://doi.org/10.1007/s10072-022-06501-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-022-06501-1